An official website of the United States government
Publication Information
Authors
Damron Kelli Collins, Friedman Robert, Inker Lesley A., Thompson Aliza, Grams Morgan E., Guðmundsdóttir Hrefna, Willis Kerry, Manley Tom, Heerspink Hiddo L., Weiner Daniel E.
Studies
Abstract
With a growing number of medications and therapies available to treat chronic kidney disease (CKD), risk-versus-benefit discussions are increasingly critical. Balancing risks and benefits requires assessing patients’ understanding of these, as well as incorporating patient preferences and tolerance for side effects into shared decision making.